Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1

Abroad (travel likely)Recruiting

Conditions

Neurofibroma · Neurofibroma, Plexiform

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Centre Leon Berard, Lyon, France
Contact: Study coordinator (Patrick COMBEMALE) · patrick.combemale@lyon.unicancer.fr · +3304 78 78 59 96
Contact: Principal Investigator (Patrick COMBEMALE)
Amine BOUHAMAMA (Sub-investigator)
Frank PILLEUL (Sub-investigator)
Mona AMINI-ADLE (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

Neurofibroma, Plexiform · Precursor Cell Lymphoblastic Leukemia-Lymphoma · Leukemia, Promyelocytic, Acute

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Real-World Treatment Study of Koselugo (Selumetinib)

Neurofibromatosis 1 · Neurofibroma, Plexiform

Abroad (travel likely)Recruiting

Busan, South Korea · Chungcheongbuk-do, South Korea

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas

NF1 Mutation · Neurofibroma Plexiform · Neurofibroma, Plexiform

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · St Leonards, Australia

Clinical and Demographic Characteristics of Adult p Atients With NEurofibromatosis in RUSsia

Neurofibromatosis

Abroad (travel likely)Recruiting

Arkhangelsk, Russia · Chelyabinsk, Russia